Education
About Us
Working with TipRanks
Follow Us
Fisher & Paykel Healthcare Corporation Limited (AU:FPH)
ASX:FPH
FPH Stock Chart & Stats
AU$32.33
AU$0.04(0.12%)
At close: 4:00 PM EST
AU$32.33
AU$0.04(0.12%)
Day’s Range― - ―
52-Week RangeAU$29.08 - AU$35.75
Previous CloseN/A
Volume151.81K
Average Volume (3M)485.38K
Market Cap
$18.60B
Enterprise ValueAU$11.16B
Total Cash (Recent Filing)$264.50M
Total Debt (Recent Filing)$153.30M
Price to Earnings (P/E)53.5
Beta0.43
Next Earnings
Nov 25, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 23, 2025Dividend Yield1.17%
Share Statistics
EPS (TTM)0.34
Shares Outstanding587,262,900
10 Day Avg. Volume621,556
30 Day Avg. Volume485,379
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.60
Enterprise Value/Revenue5.00
Enterprise Value/Gross Profit9.97
Enterprise Value/Ebitda12.00
Forecast
1Y Price Target
$39.41Price Target Upside21.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Fisher & Paykel Healthcare Corporation Limited News
FPH FAQ
What was Fisher & Paykel Healthcare Corporation Limited’s price range in the past 12 months?
Fisher & Paykel Healthcare Corporation Limited lowest share price was AU$29.08 and its highest was AU$35.74 in the past 12 months.
What is Fisher & Paykel Healthcare Corporation Limited’s market cap?
Fisher & Paykel Healthcare Corporation Limited’s market cap is $18.60B.
When is Fisher & Paykel Healthcare Corporation Limited’s upcoming earnings report date?
Fisher & Paykel Healthcare Corporation Limited’s upcoming earnings report date is Nov 25, 2025 which is in 22 days.
How were Fisher & Paykel Healthcare Corporation Limited’s earnings last quarter?
Fisher & Paykel Healthcare Corporation Limited released its earnings results on May 27, 2025. The company reported AU$0.341 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.341.
Is Fisher & Paykel Healthcare Corporation Limited overvalued?
According to Wall Street analysts Fisher & Paykel Healthcare Corporation Limited’s price is currently Undervalued.
Does Fisher & Paykel Healthcare Corporation Limited pay dividends?
Fisher & Paykel Healthcare Corporation Limited pays a Notavailable dividend of AU$0.223 which represents an annual dividend yield of 1.17%. See more information on Fisher & Paykel Healthcare Corporation Limited dividends here
What is Fisher & Paykel Healthcare Corporation Limited’s EPS estimate?
Fisher & Paykel Healthcare Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fisher & Paykel Healthcare Corporation Limited have?
Fisher & Paykel Healthcare Corporation Limited has 587,262,900 shares outstanding.
What happened to Fisher & Paykel Healthcare Corporation Limited’s price movement after its last earnings report?
Fisher & Paykel Healthcare Corporation Limited reported an EPS of AU$0.341 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.776%.
Which hedge fund is a major shareholder of Fisher & Paykel Healthcare Corporation Limited?
Currently, no hedge funds are holding shares in AU:FPH
Company Description
Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
FPH Stock 12 Month Forecast
Average Price Target
AU$39.41
▲(21.90% Upside)
Technical Analysis
Fisher & Paykel Healthcare Corporation Limited
―
Resmed
―
Inogen
―
Masimo
―
Insulet
―
Lemaitre Vascular
―
Globus Medical
―
Options Prices
Currently, No data available
---